4-(2-((1R,2S)-2-(2,5-DIFLUOROPHENYL)-2-HYDROXY-1-METHYL-3-(1H-1,2,4-TRIAZOL-1-YL)PROPYL)-4-THIAZOLYL)BENZONITRILE, REL-
UNII DCE3XV8M6Y
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-((1r,2s)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)benzonitrile, Rel-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DCE3XV8M6Y.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1797905-83-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H17F2N5OS DDFOUSQFMYRUQK-FPTDNZKUSA-N;DDFOUSQFMYRUQK-JLCFBVMHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-((1r,2s)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)benzonitrile, Rel-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.